| molecular function |
|---|
| | GO:0008083 | | growth factor activity | | The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation. |
| | GO:0005179 | | hormone activity | | The action characteristic of a hormone, any substance formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells in the same organism, upon which it has a specific regulatory action. The term was originally applied to agents with a stimulatory physiological action in vertebrate animals (as opposed to a chalone, which has a depressant action). Usage is now extended to regulatory compounds in lower animals and plants, and to synthetic substances having comparable effects; all bind receptors and trigger some biological process. |
| | GO:0005158 | | insulin receptor binding | | Interacting selectively and non-covalently with the insulin receptor. |
| | GO:0005159 | | insulin-like growth factor receptor binding | | Interacting selectively and non-covalently with the insulin-like growth factor receptor. |
| | GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| | GO:0043539 | | protein serine/threonine kinase activator activity | | Binds to and increases the activity of a protein serine/threonine kinase. |
| | GO:0030546 | | receptor activator activity | | The function of interacting (directly or indirectly) with receptors such that the proportion of receptors in the active form is increased. |
| biological process |
|---|
| | GO:0005975 | | carbohydrate metabolic process | | The chemical reactions and pathways involving carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y. Includes the formation of carbohydrate derivatives by the addition of a carbohydrate residue to another molecule. |
| | GO:0044267 | | cellular protein metabolic process | | The chemical reactions and pathways involving a specific protein, rather than of proteins in general, occurring at the level of an individual cell. Includes cellular protein modification. |
| | GO:0071260 | | cellular response to mechanical stimulus | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus. |
| | GO:0007565 | | female pregnancy | | The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth. |
| | GO:0006006 | | glucose metabolic process | | The chemical reactions and pathways involving glucose, the aldohexose gluco-hexose. D-glucose is dextrorotatory and is sometimes known as dextrose; it is an important source of energy for living organisms and is found free as well as combined in homo- and hetero-oligosaccharides and polysaccharides. |
| | GO:0008286 | | insulin receptor signaling pathway | | The series of molecular signals generated as a consequence of the insulin receptor binding to insulin. |
| | GO:0038028 | | insulin receptor signaling pathway via phosphatidylinositol 3-kinase | | The series of molecular signals generated as a consequence of the insulin receptor binding to its physiological ligand, where the signal is passed on via the phosphatidylinositol 3-kinase cascade. |
| | GO:0007613 | | memory | | The activities involved in the mental information processing system that receives (registers), modifies, stores, and retrieves informational stimuli. The main stages involved in the formation and retrieval of memory are encoding (processing of received information by acquisition), storage (building a permanent record of received information as a result of consolidation) and retrieval (calling back the stored information and use it in a suitable way to execute a given task). |
| | GO:0007275 | | multicellular organism development | | The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult). |
| | GO:0045953 | | negative regulation of natural killer cell mediated cytotoxicity | | Any process that stops, prevents, or reduces the rate of natural killer mediated cytotoxicity. |
| | GO:0001503 | | ossification | | The formation of bone or of a bony substance, or the conversion of fibrous tissue or of cartilage into bone or a bony substance. |
| | GO:0002576 | | platelet degranulation | | The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet. |
| | GO:0043410 | | positive regulation of MAPK cascade | | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the MAPK cascade. |
| | GO:0042104 | | positive regulation of activated T cell proliferation | | Any process that activates or increases the rate or extent of activated T cell proliferation. |
| | GO:0043085 | | positive regulation of catalytic activity | | Any process that activates or increases the activity of an enzyme. |
| | GO:0051781 | | positive regulation of cell division | | Any process that activates or increases the frequency, rate or extent of cell division. |
| | GO:0008284 | | positive regulation of cell proliferation | | Any process that activates or increases the rate or extent of cell proliferation. |
| | GO:2000467 | | positive regulation of glycogen (starch) synthase activity | | Any process that activates or increases the frequency, rate or extent of glycogen (starch) synthase activity. |
| | GO:0045725 | | positive regulation of glycogen biosynthetic process | | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of glycogen. |
| | GO:0046628 | | positive regulation of insulin receptor signaling pathway | | Any process that increases the frequency, rate or extent of insulin receptor signaling. |
| | GO:0045840 | | positive regulation of mitotic nuclear division | | Any process that activates or increases the frequency, rate or extent of mitosis. |
| | GO:0050731 | | positive regulation of peptidyl-tyrosine phosphorylation | | Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine. |
| | GO:0051897 | | positive regulation of protein kinase B signaling | | Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B. |
| | GO:0001934 | | positive regulation of protein phosphorylation | | Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein. |
| | GO:0071902 | | positive regulation of protein serine/threonine kinase activity | | Any process that increases the rate, frequency, or extent of protein serine/threonine kinase activity. |
| | GO:2000273 | | positive regulation of receptor activity | | Any process that activates or increases the frequency, rate or extent of receptor activity. |
| | GO:0006349 | | regulation of gene expression by genetic imprinting | | Heritable alterations in the activity of a gene that depend on whether it passed through the paternal or the maternal germline, but that are not encoded by DNA itself. |
| | GO:0006355 | | regulation of transcription, DNA-templated | | Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription. |
| | GO:0042493 | | response to drug | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease. |
| | GO:0032355 | | response to estradiol | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen. |
| | GO:0045471 | | response to ethanol | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus. |
| | GO:0035094 | | response to nicotine | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nicotine stimulus. |
| | GO:0031667 | | response to nutrient levels | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting the presence, absence, or concentration of nutrients. |
| | GO:0014070 | | response to organic cyclic compound | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus. |
| | GO:0009314 | | response to radiation | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an electromagnetic radiation stimulus. Electromagnetic radiation is a propagating wave in space with electric and magnetic components. These components oscillate at right angles to each other and to the direction of propagation. |
| | GO:0001501 | | skeletal system development | | The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton). |
| | GO:0042060 | | wound healing | | The series of events that restore integrity to a damaged tissue, following an injury. |
| cellular component |
|---|
| | GO:0070062 | | extracellular exosome | | A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. |
| | GO:0005576 | | extracellular region | | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
| | GO:0005615 | | extracellular space | | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
| | GO:0005886 | | plasma membrane | | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
| | GO:0031093 | | platelet alpha granule lumen | | The volume enclosed by the membrane of the platelet alpha granule. |
Description
